Clinical trial

RISE Adult Medication Study

NCT01779362

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE3

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2023-05-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prediabetesunresolved

Type 2 Diabetesunresolved

Interventions

MetforminDRUG · verified · RxNorm: metformin

LiraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

RISE Study Grouplead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

ChicagoIllinois, United States2 SeattleWashington, United States1 IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01779362 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.